Journal Home
Search for

Volume 19, Issue 6, Pages 486-491 (December 2008)


View previous. 9 of 10 View next.

Is groin injecting an ethical boundary for harm reduction?

Peter G. MilleraCorresponding Author Informationemail address, Nick Lintzerisabemail address, Luciana Forzisia1email address

Received 3 July 2007; received in revised form 4 October 2007; accepted 4 October 2007. published online 19 November 2007.

Abstract 

Background

Femoral vein (or groin) injecting by street drug users is an emerging public health issue in the UK. It has been proposed that groin injecting is becoming normalised among UK injecting drug users (IDUs), yet harm reduction strategies are currently piecemeal and some may be crossing the boundary of responsible provision of information. This paper discusses the interventions available to service providers dealing with groin injecting and explores the utility of ethical frameworks for informing service provider decisions.

Methods

Methods analysis of possible service provider responses using White and Popovits’ ethical decision-making framework.

Results

The use of ethical frameworks suggest that different types of groin injectors should receive different interventions. Injectors for whom the groin is a site of ‘last resort’ should be given information about how to inject there less dangerously, whereas ‘convenience’ groin injectors should be actively encouraged to inject elsewhere.

Conclusion

Groin injecting is a behaviour which represents a boundary for some harm reduction practices (such as providing ‘how to’ booklets to all injectors) as well as being an argument for more complex and environmentally appropriate harm reduction responses such as drug consumption rooms and training IDUs to maintain healthier injecting sites.

a National Addiction Centre, Institute of Psychiatry, King's College London, SE5 8AF, UK

b Drug Health Services, Sydney South West Area Health Service, c/o Royal Prince Alfred Hospital, Page Building Level 5, Missenden Road, Camperdown, Sydney, NSW 2050, Australia

Corresponding Author InformationCorresponding author. Fax: +44 20 7701 8454.

1 Fax: +44 20 7701 8454.

PII: S0955-3959(07)00213-7

doi:10.1016/j.drugpo.2007.10.001


View previous. 9 of 10 View next.